Risk Assessment of Thromboembolic Disease In Patients Treated For Multiple Myeloma

被引：0
|
作者：
Douma, Soukaina [1 ]
Naim, Sara [1 ]
Benmoussa, Amine [1 ]
Berrada, Sophia [1 ]
Lamchahab, Mouna [1 ]
Khoubila, Nissrine [1 ]
Rachid, Mohammed [1 ]
Qachouh, Meryem [1 ]
Cherkaoui, Siham [1 ]
Madani, Abdellah [1 ]
机构：
[1] Univ Hosp, Ctr IBN ROCHD, Casablanca, Morocco
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-556
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [31] Using Mass Spectrometry to Assess Disease Status in Treated Multiple Myeloma Patients
    Campbell, Lauren
    Ramasamy, Karthik
    Sadler, Ross
    BLOOD, 2023, 142
  • [32] Thromboembolic risk in dermatomyositis patients treated with intravenous immunoglobulin
    Chang, C. T.
    Khattab, S.
    Shaw, K.
    Tang, K.
    Vleugels, R.
    Semenov, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S6 - S6
  • [33] Treatment options for multiple myeloma patients with high-risk disease
    Ailawadhi, Sikander
    Masood, Aisha
    Sher, Taimur
    Miller, Kena C.
    Wood, Margaret
    Lee, Kelvin
    Chanan-Khan, Asher
    MEDICAL ONCOLOGY, 2010, 27 : 53 - 61
  • [34] Treatment options for multiple myeloma patients with high-risk disease
    Sikander Ailawadhi
    Aisha Masood
    Taimur Sher
    Kena C. Miller
    Margaret Wood
    Kelvin Lee
    Asher Chanan-Khan
    Medical Oncology, 2010, 27 : 53 - 61
  • [35] Flow Cytometry Assessment of Residual Disease and Engraftment Outcome in Multiple Myeloma Patients Treated with Hematopoietic Progenitor Cell Products
    Javanbakht, A.
    Grewal, S.
    Yee, M.
    Hendrickson, J.
    Waller, E.
    Sullivan, H.
    TRANSFUSION, 2024, 64 : 77A - 78A
  • [36] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
    Charalampous, Charalampos
    Kourelis, Taxiarchis
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [37] Characteristics of patients experiencing thromboembolic events during treatment for multiple myeloma: Aspirin may not be adequate thromboprophylaxis in patients with multiple risk factors.
    Wright, Jennifer A.
    Weber, Donna
    Thomas, Sheeba K.
    Wang, Michael
    Alexanian, Raymond
    Hawkins, Victoria E.
    Vadhan-Raj, Saroj
    BLOOD, 2007, 110 (11) : 557A - 557A
  • [38] Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone
    Ulrike Klein
    Florentina Kosely
    Jens Hillengaß
    Michael Hundemer
    Stefan Schmitt
    Kai Neben
    Thomas Moehler
    Ute Hegenbart
    Anthony D. Ho
    Hartmut Goldschmidt
    Annals of Hematology, 2009, 88
  • [39] Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone
    Klein, Ulrike
    Kosely, Florentina
    Hillengass, Jens
    Hundemer, Michael
    Schmitt, Stefan
    Neben, Kai
    Moehler, Thomas
    Hegenbart, Ute
    Ho, Anthony D.
    Goldschmidt, Hartmut
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 67 - 71
  • [40] A Survey of UK Myeloma treating centres on thrombosis risk assessment and thromboprophylaxis practice in patients with Multiple Myeloma
    Oliver, R.
    Bygrave, C.
    Cook, G.
    Jackson, G.
    Bradbury, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 130 - 131
12345